Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.

Ozempic — or any of the GLP-1 class of diet drugs that includes Wegovy and Mounjaro — hasn’t just changed our nation’s ...

The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...

People taking new weight-loss drugs say they curb cravings for booze, drugs, and nicotine. Did scientists inadvertently ...

It would give millions of people access to weekly injectables that have helped people shed pounds so quickly that some people ...

About 7.4 million Americans with obesity could have insurance coverage for drugs like Wegovy if the Trump administration ...

There has been a lot of conversation lately about if new weight loss drugs like Wegovy and Mounjaro should be covered by ...

A new weight loss drug could see patients lose double the amount ... Wegovy and Mounjaro in the last three months of 2022, with companies racing to expand supply to meet the demand.

Wednesday, November 30, 2022. Graham has battled excess weight for years, cycling through trendy diets, various drugs, and even bariatric surgery. she started a new medication, Mounjaro ...

Editor's Note: The following is part of a class project originally initiated in the classroom of Ball State University ...